The independent source for health policy research, polling, and news.
Showing 61 - 80 of 115
Since 2017, Medicaid expansion has been adopted in seven states where a question was placed directly on the ballot. But campaign leaders say that strategy may not work in Florida and Wyoming, where Republican opposition remains strong.
Private equity-backed Headlands Research heralded its covid-19 vaccine trials as a chance to boost participation among diverse populations, then it shuttered multiple sites that conducted them.
In Minnesota, where abortion rights are protected by the state’s constitution, legal doesn't necessarily mean accessible. The state has just eight clinics that provide abortions, and both providers and advocates say resources available aren’t enough to meet demand as nearby states reduce abortion access.
By undoing that landmark decision, the law of the land since 1973, the court has empowered states to set their own abortion restrictions — so where people live will determine their level of access.
The pandemic crisis has overwhelmed understaffed state Medicaid agencies, already delaying access to the insurance program in Missouri. As the public health emergency ends, low-income people nationwide could find it even harder to have coverage.
Federal data shows that vaccination rates for American Indians and Alaska Natives were some of the highest in the nation, but tribes say resistance has slowed efforts to boost members.
The South Carolina senator led the congressional pack in pharma campaign contributions for the second half of 2021. There are clear reasons.
CMS chief Chiquita Brooks-LaSure says the agency reserves its power to quickly institute new regulations for “absolute emergencies.” On staffing, nursing home residents might need to wait years to see any real change.
State Medicaid agencies for months have been preparing for the end of a federal mandate that has prevented states from removing people from the safety-net program during the pandemic.
As omicron surges, more nursing homes are facing a double whammy: Lab tests are taking too long, and fast antigen tests are in short supply.
Just 18% of 5- to 11-year-olds are fully vaccinated, with rates varying significantly across the country, a KHN analysis of federal data shows. Pediatricians say the slow pace and geographic disparities are alarming, especially against the backdrop of record numbers of cases and pediatric hospitalizations.
As hospitals juggle holiday covid surges and all their other patients, the global supply chain crisis has left them short of critical supplies.
You probably won’t be testing everyone at your Thanksgiving table for covid because the tests are expensive and hard to find. Why? The federal government is partly to blame.
KHN answers questions for seniors about how this new benefit might work.
With an eye to shutting down Medicare drug price negotiations, drug companies and their lobbying groups gave roughly $1.6 million in the first six months of 2021, with Democrats edging closer than they have in a decade to Republicans’ total haul.
Federally qualified health centers from California to Michigan are mired in a bureaucratic mess over how they should be paid under Medicaid for each dose of covid vaccine given. In California alone, clinics await reimbursement for at least 1 million shots, causing a “massive cash flow problem.”
The Food and Drug Administration has been mired in controversies related to drug approvals and covid vaccines, all without a permanent leader.
Back-to-school season has fueled immediate covid outbreaks. Instead of beefing up protections, some districts are letting students go without masks, physical distancing and quarantines. And parents are left to make impossibly tough decisions.
Missouri’s ambitious school testing plan landed with a thud. What it can teach us now about keeping the delta variant out of classrooms.
Many experts say the evidence doesn’t justify widespread booster shots for adults.
Stay informed by signing up for the Morning Briefing and other emails:
© 2026 KFF